Premium
Halozyme Therapeu Dl 001 (RV7)
TG
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Dr. Helen I. TorleyPresident, CEO & Director | -50,00k | 2,77M | Derivative Exercise and Sale | 12,07 - 69,69 | 767,78k | - |
| 2026-06-01 | Ms. Bernadette Mary ConnaughtonIndependent Director | -1,63k | 107,59k | Automatic Disposition | 66,21 | 36,87k | -4,22% |
| 2026-05-11 | Dr. Helen I. TorleyPresident, CEO & Director | -50,00k | 2,83M | Derivative Exercise and Sale | 12,07 - 73,12 | 767,78k | - |
| 2026-05-01 | Ms. Bernadette Mary ConnaughtonIndependent Director | -1,63k | 103,16k | Automatic Disposition | 63,48 | 38,50k | -4,05% |
| 2026-04-06 | Dr. Helen I. TorleyPresident, CEO & Director | -10,00k | 514,28k | Derivative Exercise and Sale | 12,07 - 64,02 | 767,78k | - |
| 2026-04-01 | Dr. Helen I. TorleyPresident, CEO & Director | -40,00k | 2,11M | Derivative Exercise and Sale | 12,07 - 65,71 | 767,78k | - |
| 2026-03-09 | Ms. Cortney CaudillSenior VP & COO | -21,55k | 738,64k | Derivative Exercise and Sale | 33,51 - 68,25 | 7,06k | - |
| 2026-03-10 | Ms. Cortney CaudillSenior VP & COO | -7,31k | 494,52k | Vente | 67,64 | 7,06k | -50,89% |
| 2026-03-02 | Dr. Helen I. TorleyPresident, CEO & Director | -50,00k | 2,87M | Derivative Exercise and Sale | 12,07 - 70,95 | 767,78k | - |
| 2026-02-20 | Ms. Cortney CaudillSenior VP & COO | 1,63k | 0,00 | Derivative Exercise and Retained Stock | - | 14,37k | 12,79% |
| 2026-02-20 | Ms. Cortney CaudillSenior VP & COO | -1,04k | 73,61k | Derivative Exercise and Sale | 70,98 | 14,37k | - |
| 2026-02-20 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | 5,69k | 0,00 | Derivative Exercise and Retained Stock | - | 47,61k | 13,56% |
| 2026-02-20 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | -6,66k | 471,30k | Derivative Exercise and Sale | 70,64 - 70,98 | 47,61k | - |
| 2026-02-20 | Ms. Nicole LaBrosseInitié | 5,54k | 0,00 | Derivative Exercise and Retained Stock | - | 38,49k | 16,80% |
| 2026-02-20 | Ms. Nicole LaBrosseInitié | -6,48k | 459,01k | Derivative Exercise and Sale | 70,64 - 70,98 | 38,49k | - |
| 2026-02-20 | Dr. Helen I. TorleyPresident, CEO & Director | 18,05k | 0,00 | Derivative Exercise and Retained Stock | - | 767,78k | 2,41% |
| 2026-02-20 | Dr. Helen I. TorleyPresident, CEO & Director | -21,14k | 1,50M | Derivative Exercise and Sale | 70,64 - 70,98 | 767,78k | - |
| 2026-02-16 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | 7,74k | 0,00 | Derivative Exercise and Retained Stock | - | 41,93k | 22,66% |
| 2026-02-16 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | -9,07k | 720,36k | Derivative Exercise and Sale | 79,44 | 41,93k | - |
| 2026-02-16 | Ms. Nicole LaBrosseInitié | 10,88k | 0,00 | Derivative Exercise and Retained Stock | - | 32,96k | 49,27% |
| 2026-02-16 | Ms. Nicole LaBrosseInitié | -12,89k | 1,02M | Derivative Exercise and Sale | 79,44 | 32,96k | - |
| 2026-02-16 | Dr. Helen I. TorleyPresident, CEO & Director | 41,01k | 0,00 | Derivative Exercise and Retained Stock | - | 749,73k | 5,79% |
| 2026-02-16 | Dr. Helen I. TorleyPresident, CEO & Director | -48,04k | 3,82M | Derivative Exercise and Sale | 79,44 | 749,73k | - |
| 2026-02-03 | Dr. Helen I. TorleyPresident, CEO & Director | -50,00k | 3,25M | Derivative Exercise and Sale | 12,07 - 78,94 | 708,72k | - |
| 2026-01-05 | Ms. Bernadette Mary ConnaughtonIndependent Director | -2,00k | 140,50k | Automatic Disposition | 70,25 | 35,96k | -5,27% |
| 2026-01-03 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | 3,37k | 0,00 | Derivative Exercise and Retained Stock | - | 34,18k | 10,93% |
| 2026-01-03 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | -4,24k | 298,33k | Derivative Exercise and Sale | 70,31 | 34,18k | - |
| 2025-11-01 | Ms. Cortney CaudillSenior VP & COO | 5,06k | 0,00 | Derivative Exercise and Retained Stock | - | 12,74k | 65,98% |
| 2025-11-01 | Ms. Cortney CaudillSenior VP & COO | -4,26k | 277,90k | Derivative Exercise and Sale | 65,19 | 12,74k | - |
| 2025-12-01 | Ms. Bernadette Mary ConnaughtonIndependent Director | -829,00 | 59,36k | Automatic Disposition | 71,60 | 37,96k | -2,14% |
| 2025-12-01 | Dr. Helen I. TorleyPresident, CEO & Director | -16,57k | 1,01M | Derivative Exercise and Sale | 8,11 - 71,60 | 708,72k | - |
| 2025-11-26 | Dr. Helen I. TorleyPresident, CEO & Director | -25,00k | 0,00 | Other Disposition | - | 708,72k | -3,41% |
| 2025-11-10 | Dr. Helen I. TorleyPresident, CEO & Director | -60,00k | 3,68M | Derivative Exercise and Sale | 8,11 - 71,67 | 733,72k | - |
| 2025-11-10 | Ms. Bernadette Mary ConnaughtonIndependent Director | -2,00k | 136,96k | Automatic Disposition | 68,48 | 38,79k | -4,90% |
| 2025-10-01 | Dr. Helen I. TorleyPresident, CEO & Director | -60,00k | 3,83M | Derivative Exercise and Sale | 8,11 - 75,69 | 733,72k | - |
| 2025-10-01 | Ms. Bernadette Mary ConnaughtonIndependent Director | -2,00k | 150,48k | Automatic Disposition | 75,09 - 75,70 | 40,79k | -4,67% |
| 2025-09-22 | Ms. Nicole LaBrosseInitié | -2,23k | 173,58k | Automatic Disposition | 77,83 - 78,67 | 22,08k | -9,16% |
| 2025-09-10 | Ms. Nicole LaBrosseInitié | -12,41k | 787,45k | Derivative Exercise and Sale | 12,07 - 75,93 | 24,31k | - |
| 2025-09-10 | Ms. Nicole LaBrosseInitié | -7,59k | 576,60k | Automatic Disposition | 75,93 | 24,31k | -23,81% |
| 2025-09-02 | Dr. Helen I. TorleyPresident, CEO & Director | -60,00k | 3,96M | Derivative Exercise and Sale | 8,11 - 75,22 | 733,72k | - |
| 2025-09-02 | Ms. Bernadette Mary ConnaughtonIndependent Director | -4,00k | 294,74k | Automatic Disposition | 71,71 - 74,11 | 42,79k | -8,55% |
| 2025-08-11 | Dr. Helen I. TorleyPresident, CEO & Director | -60,00k | 3,33M | Derivative Exercise and Sale | 8,11 - 64,83 | 733,72k | - |
| 2025-07-08 | Dr. Helen I. TorleyPresident, CEO & Director | -60,00k | 2,90M | Derivative Exercise and Sale | 8,11 - 57,62 | 733,72k | - |
| 2025-06-20 | Dr. Helen I. TorleyPresident, CEO & Director | -60,00k | 2,70M | Derivative Exercise and Sale | 8,11 - 53,91 | 733,72k | - |
| 2025-06-12 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | 2,32k | 0,00 | Derivative Exercise and Retained Stock | - | 30,81k | 8,16% |
| 2025-06-12 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | -2,71k | 147,86k | Derivative Exercise and Sale | 54,54 | 30,81k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
